The immunobiology of cancer immunosurveillance and immunoediting.
Explore this paper's citation graph
Summary
The full understanding of the immunobiology of cancer immunosurveillance and immunoediting will hopefully stimulate development of more effective immunotherapeutic approaches to control and/or eliminate human cancers.
- Type
- review
- Published
- 2004-08-01
- Cited by
- 2,958
- References
- 119
- Access
- Open access
- OpenAlex
- https://openalex.org/W2019214729
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:34665353
Keywords
Immunoediting, Immunosurveillance, Biology, Cancer, Tumor immunology
References
- Decreased tumor surveillance in perforin-deficient mice
- MIC genes: from genetics to biology.
- The tumor dormant state.
- Donor transmitted disease: cancer.
- The concept of immunological surveillance.
- Receptor-Mediated Monitoring of Tissue Well-Being Via Detection of Soluble Heparan Sulfate by Toll-Like Receptor 41
- Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor.
- Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.
- Increased Susceptibility to Tumor Initiation and Metastasis in TNF-Related Apoptosis-Inducing Ligand-Deficient Mice1
- Mutator phenotype may be required for multistage carcinogenesis.
- NKT cell–mediated repression of tumor immunosurveillance by IL-13 and the IL-4R–STAT6 pathway
- Genetic instabilities in human cancers
- Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.
- Cutting Edge: Heat Shock Protein 60 Is a Putative Endogenous Ligand of the Toll-Like Receptor-4 Complex1
- Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
- A fresh look at tumor immunosurveillance and immunotherapy
- Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages
- IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
- Critical Role of MHC Class I-Related Chain A and B Expression on IFN-α-Stimulated Dendritic Cells in NK Cell Activation: Impairment in Chronic Hepatitis C Virus Infection 1
- Cancer dormancy: studies of the murine BCL1 lymphoma.
Cited by
- Antitumor-associated antigens IgGs: dual positive and negative potential effects for cancer therapy.
- The role of TIM-1 in enveloped virus entry
- Innate immune recognition and suppression of tumors.
- Interferons, immunity and cancer immunoediting
- Hlx homeobox transcription factor negatively regulates interferon-gamma production in monokine-activated natural killer cells.
- Immune based therapies in cancer.
- Immune-refractory cancers and their little helpers--an extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?
- The role of interferon gamma in regulation of CD4+ T-cells and its clinical implications.
- Liposomes targeting tumour stromal cells
- Lymphocytes genetically modified to express tumor antigens target dendritic cells in vivo and induce antitumor immunity
- Potential rescue, survival and differentiation of cancer stem cells and primary non-transformed stem cells by monocyte-induced split anergy in natural killer cells
- Probiotics, dendritic cells and bladder cancer
- Assessment of the humoral immune response to cancer.
- Pathway-Based Evaluation in Early Onset Colorectal Cancer Suggests Focal Adhesion and Immunosuppression along with Epithelial-Mesenchymal Transition
- The kynurenine pathway in brain tumor pathogenesis.
- Vitamin D—Effects on Skeletal and Extraskeletal Health and the Need for Supplementation
- Glioblastoma Metastasis to Parotid Gland and Neck Lymph Nodes: Fine-Needle Aspiration Cytology with Histopathologic Correlation
- Dendritic cell-based immunotherapy in myeloid leukaemia: translating fundamental mechanisms into clinical applications.
- CTLA-4 and PD-1 Pathways
- Cancer immune contexture and immunotherapy.
Related papers
- Biotechnology: Proteins to PCR (1995): By D W Burden and D B Whitney. pp 336. Birkhãuser, Basel. 1995. SFr118/58 (soft cover) ISBN 0‐8176‐384‐1
- Human leukocyte antigen-G and cancer immunoediting.
- Immunosurveillance and immunoediting in MMTV-PyMT-induced mammary oncogenesis
- The three Es of cancer immunoediting.
- Cancer Immunosurveillance and Immunoediting by Natural Killer Cells
- Cancer immunoediting: from immunosurveillance to tumor escape
- Immunosurveillance and Oral Cancer
- Elucidating tumor immunosurveillance and immunoediting: a comprehensive review